Home / News / SHL Medical / SHL Medical joins DCAT Week 2024
Events| February 23, 2024

SHL Medical joins DCAT Week 2024

SHL Medical attends DCAT Week 2024 at Suite #2302 Lexington Hotel New York on March 18-21.
Connect with SHL Medical’s experts at Suite #2302 Lexington Hotel New York

SHL Medical will be in New York, USA on March 18-21 for DCAT Week 2024. As a key participant, we are eager to exchange knowledge on the latest advancements in the pharmaceutical and biotechnology sectors and explore opportunities for future partnerships that align with our commitment to innovation and collaboration.

In 2023, SHL Medical introduced the Alliance Management Program – an initiative that promotes collaboration to facilitate efficient development of innovative autoinjector solutions. Each partner within the alliance brings their expertise, recommendations, and competencies to the table, ensuring a tailor-made approach to meet the specific needs of different combination products development.

In addition, visitors can also learn more about our end-to-end development processes and comprehensive manufacturing capabilities. SHL Medical’s facility in Florida offers various Contract Manufacturing (CMO) services – from a wide range of analytical services to final assembly, labeling, and packaging, as well as design transfer.

We look forward to sharing our expertise and fostering meaningful connections within the pharmaceutical community at DCAT Week 2024!

In the meantime, check out our webinar on design transfer to understand the significance of design transfer and how to achieve effective design transfer processes.

 

Where   : The Lexington Hotel New York, USA | Suite #2302

When    : March 18-21

About SHL Medical

As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by our company purpose – Enabling Patients’ Independence – we offer patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. We also offer final assembly, labeling, and packaging solutions for our drug delivery systems.  ​

In response to the rising trend in home therapy, SHL has increased developmental work in the digital healthcare sector to help improve the drug delivery ecosystem. ​

Located across Switzerland, Taiwan, Sweden, and the US, our global team of experts collaborate seamlessly as one team in utilizing our comprehensive in-house manufacturing capabilities. Our solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into our designs and processes to contribute to a cleaner earth.​

For additional information, visit www.shl-medical.com

Media contact: info@shl-medical.com

Share:

Related News